Background: In order to evaluate whether single-dose ophthalmic preparation
s in 0.5-ml containers can safely be used within 24 h after the first openi
ng, eigth different sterile ocular medications containing timolol, jaluroni
c acid, diclofenac, ketotifen, pilocarpine, formocortal, formocortal-gentam
ycin, and tetryzoline-feniramine (Farmigea, Italy) were opened and tested f
or spontaneous bacterial contamination after exposure to air. Methods: Samp
les (10 yl) were collected from exposed ophthalmic preparations after 0, 2,
4, 8 and 24 h. Results: No viable microorganisms were detected during and
at the end of the evaluation period. In order to assess whether the residen
t or pathogenic ocular bacterial population due to repeated handling might
contaminate the medications, about 10(5) cells of different species (Staphy
lococcus aureus, coagulase-negative staphylococci, Streptococcus pneumoniae
, Streptococcus spp., Corynebacterium spp., Pseudomonas aeruginosa, Neisser
ia spp., Acinetobacter spp., Haemophilus influenzae, Escherichia coliand Ca
ndida albicans) were added to the containers and incubated at 37 degreesC o
r at room temperature. Samples were collected and the number of viable bact
eria was estimated. The antibacterial effect of the ophthalmic compounds va
ried depending on the species considered. Tetryzoline-feniramine, pilocarpi
ne, ketotifen and formocortal-gentamycin exhibited a frank bactericidal act
ivity (< 100 survivors after 18-24 h of exposure) against the great majorit
y of the species tested. Conclusion: These results indicate that the risk o
f spontaneous contamination of ophthalmic preparations after their first op
ening is low, and that all preparations tested exhibit an aspecific antibac
terial activity. As a consequence, the safe usage of these ocular medicatio
ns could be extended from the recommended 3 h to at least 24 h after the fi
rst usage. Copyright (C) 2001 S.Karger AG, Basel.